Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1993 Apr;37(4):692–695. doi: 10.1128/aac.37.4.692

Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice.

T Lazard 1, C Perronne 1, Y Cohen 1, J Grosset 1, J L Vilde 1, J J Pocidalo 1
PMCID: PMC187736  PMID: 7684213

Abstract

We compared the activities of two different biological-response modifiers with that of clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice. Mice were pretreated daily with clarithromycin (50 mg/kg of body weight subcutaneously [s.c.]), RU-40555 (100 mg/kg s.c.), or granulocyte colony-stimulating factor (G-CSF) at low dose (15 micrograms/kg intraperitoneally [i.p.]) or high dose (300 micrograms/kg i.p.) 3 days before intravenous challenge with 2.5 x 10(7) CFU of the MO-1 strain of M. avium complex. Mice were treated daily until sacrifice at day 1, 8, 15, or 21 after challenge, and the numbers of CFU were measured per gram of tissue in lung and spleen. Compared at day 21 with control treatment, clarithromycin significantly decreased the level of infection in spleen (P < 0.0001) and lungs (P < 0.0001). Compared with control treatment, G-CSF at low dose had no activity, but G-CSF in combination with clarithromycin was more effective than clarithromycin alone in spleen (P < 0.05) and lungs (P < 0.015). The high dose of G-CSF was as effective as the low dose. RU-40555 alone had no beneficial activity. The RU-40555-clarithromycin combination was more effective than control treatment in spleen (P = 0.0001) and lungs (P < 0.0005) and more effective than clarithromycin alone in spleen (P < 0.009) but not in lungs. Thus, our experiments suggest that clarithromycin alone or in combination with G-CSF should be further evaluated for the prophylaxis of M. avium complex infection.

Full text

PDF
692

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cairo M. S., Mauss D., Kommareddy S., Norris K., van de Ven C., Modanlou H. Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats. Pediatr Res. 1990 Jun;27(6):612–616. doi: 10.1203/00006450-199006000-00016. [DOI] [PubMed] [Google Scholar]
  2. Cairo M. S., Plunkett J. M., Mauss D., Van de ven C. Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B Streptococcus sepsis. Blood. 1990 Nov 1;76(9):1788–1794. [PubMed] [Google Scholar]
  3. Cohen A. M., Hines D. K., Korach E. S., Ratzkin B. J. In vivo activation of neutrophil function in hamsters by recombinant human granulocyte colony-stimulating factor. Infect Immun. 1988 Nov;56(11):2861–2865. doi: 10.1128/iai.56.11.2861-2865.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dautzenberg B., Truffot C., Legris S., Meyohas M. C., Berlie H. C., Mercat A., Chevret S., Grosset J. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):564–569. doi: 10.1164/ajrccm/144.3_Pt_1.564. [DOI] [PubMed] [Google Scholar]
  5. Ellner J. J., Goldberger M. J., Parenti D. M. Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution. J Infect Dis. 1991 Jun;163(6):1326–1335. doi: 10.1093/infdis/163.6.1326. [DOI] [PubMed] [Google Scholar]
  6. Fernandes P. B., Hardy D. J., McDaniel D., Hanson C. W., Swanson R. N. In vitro and in vivo activities of clarithromycin against Mycobacterium avium. Antimicrob Agents Chemother. 1989 Sep;33(9):1531–1534. doi: 10.1128/aac.33.9.1531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Havlik J. A., Jr, Horsburgh C. R., Jr, Metchock B., Williams P. P., Fann S. A., Thompson S. E., 3rd Disseminated Mycobacterium avium complex infection: clinical identification and epidemiologic trends. J Infect Dis. 1992 Mar;165(3):577–580. doi: 10.1093/infdis/165.3.577. [DOI] [PubMed] [Google Scholar]
  8. Hebert J. C., O'Reilly M., Gamelli R. L. Protective effect of recombinant human granulocyte colony-stimulating factor against pneumococcal infections in splenectomized mice. Arch Surg. 1990 Aug;125(8):1075–1078. doi: 10.1001/archsurg.1990.01410200141022. [DOI] [PubMed] [Google Scholar]
  9. Hollingshead L. M., Goa K. L. Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions. Drugs. 1991 Aug;42(2):300–330. doi: 10.2165/00003495-199142020-00009. [DOI] [PubMed] [Google Scholar]
  10. Horsburgh C. R., Jr Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med. 1991 May 9;324(19):1332–1338. doi: 10.1056/NEJM199105093241906. [DOI] [PubMed] [Google Scholar]
  11. Jacobson M. A., Hopewell P. C., Yajko D. M., Hadley W. K., Lazarus E., Mohanty P. K., Modin G. W., Feigal D. W., Cusick P. S., Sande M. A. Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis. 1991 Nov;164(5):994–998. doi: 10.1093/infdis/164.5.994. [DOI] [PubMed] [Google Scholar]
  12. Ji B., Perani E. G., Grosset J. H. Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice. Antimicrob Agents Chemother. 1991 Mar;35(3):579–581. doi: 10.1128/aac.35.3.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kimura S., Matsuda J., Ikematsu S., Miyazono K., Ito A., Nakahata T., Minamitani M., Shimada K., Shiokawa Y., Takaku F. Efficacy of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with AIDS. AIDS. 1990 Dec;4(12):1251–1255. doi: 10.1097/00002030-199012000-00011. [DOI] [PubMed] [Google Scholar]
  14. Lieschke G. J., Burgess A. W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1). N Engl J Med. 1992 Jul 2;327(1):28–35. doi: 10.1056/NEJM199207023270106. [DOI] [PubMed] [Google Scholar]
  15. Lieschke G. J., Burgess A. W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2). N Engl J Med. 1992 Jul 9;327(2):99–106. doi: 10.1056/NEJM199207093270207. [DOI] [PubMed] [Google Scholar]
  16. Lindemann A., Herrmann F., Oster W., Haffner G., Meyenburg W., Souza L. M., Mertelsmann R. Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood. 1989 Dec;74(8):2644–2651. [PubMed] [Google Scholar]
  17. Matsumoto M., Matsubara S., Matsuno T., Ono M., Yokota T. Protective effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) against various microbial infections in neutropenic mice. Microbiol Immunol. 1990;34(9):765–773. doi: 10.1111/j.1348-0421.1990.tb01054.x. [DOI] [PubMed] [Google Scholar]
  18. Matsumoto M., Matsubara S., Matsuno T., Tamura M., Hattori K., Nomura H., Ono M., Yokota T. Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice. Infect Immun. 1987 Nov;55(11):2715–2720. doi: 10.1128/iai.55.11.2715-2720.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Miles S. A., Mitsuyasu R. T., Moreno J., Baldwin G., Alton N. K., Souza L., Glaspy J. A. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine. Blood. 1991 May 15;77(10):2109–2117. [PubMed] [Google Scholar]
  20. Mooney D. P., Gamelli R. L., O'Reilly M., Hebert J. C. Recombinant human granulocyte colony-stimulating factor and Pseudomonas burn wound sepsis. Arch Surg. 1988 Nov;123(11):1353–1357. doi: 10.1001/archsurg.1988.01400350067010. [DOI] [PubMed] [Google Scholar]
  21. Nagata S., Tsuchiya M., Asano S., Kaziro Y., Yamazaki T., Yamamoto O., Hirata Y., Kubota N., Oheda M., Nomura H. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. 1986 Jan 30-Feb 5Nature. 319(6052):415–418. doi: 10.1038/319415a0. [DOI] [PubMed] [Google Scholar]
  22. Nelson S., Summer W., Bagby G., Nakamura C., Stewart L., Lipscomb G., Andresen J. Granulocyte colony-stimulating factor enhances pulmonary host defenses in normal and ethanol-treated rats. J Infect Dis. 1991 Nov;164(5):901–906. doi: 10.1093/infdis/164.5.901. [DOI] [PubMed] [Google Scholar]
  23. Nightingale S. D., Byrd L. T., Southern P. M., Jockusch J. D., Cal S. X., Wynne B. A. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis. 1992 Jun;165(6):1082–1085. doi: 10.1093/infdis/165.6.1082. [DOI] [PubMed] [Google Scholar]
  24. Perronne C., Cohen Y., Truffot-Pernot C., Grosset J., Vildé J. L., Pocidalo J. J. Sparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 mice. Antimicrob Agents Chemother. 1992 Nov;36(11):2408–2412. doi: 10.1128/aac.36.11.2408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Perronne C., Gikas A., Truffot-Pernot C., Grosset J., Pocidalo J. J., Vilde J. L. Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages. Antimicrob Agents Chemother. 1990 Aug;34(8):1508–1511. doi: 10.1128/aac.34.8.1508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Perronne C., Gikas A., Truffot-Pernot C., Grosset J., Vilde J. L., Pocidalo J. J. Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages. Antimicrob Agents Chemother. 1991 Jul;35(7):1356–1359. doi: 10.1128/aac.35.7.1356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Pojda Z., Molineux G., Dexter T. M. Hemopoietic effects of short-term in vivo treatment of mice with various doses of rhG-CSF. Exp Hematol. 1990 Jan;18(1):27–31. [PubMed] [Google Scholar]
  28. Rastogi N., Labrousse V. Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex. Antimicrob Agents Chemother. 1991 Mar;35(3):462–470. doi: 10.1128/aac.35.3.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Schnittman S., Lane H. C., Witebsky F. G., Gosey L. L., Hoggan M. D., Fauci A. S. Host defense against Mycobacterium-avium complex. J Clin Immunol. 1988 Jul;8(4):234–243. doi: 10.1007/BF00916551. [DOI] [PubMed] [Google Scholar]
  30. Shinomiya N., Tsuru S., Katsura Y., Kayashima S., Nomoto K. Enhanced resistance against Listeria monocytogenes achieved by pretreatment with granulocyte colony-stimulating factor. Infect Immun. 1991 Dec;59(12):4740–4743. doi: 10.1128/iai.59.12.4740-4743.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sieff C. A. Hematopoietic growth factors. J Clin Invest. 1987 Jun;79(6):1549–1557. doi: 10.1172/JCI112988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Vogels M. T., van der Meer J. W. Use of immune modulators in nonspecific therapy of bacterial infections. Antimicrob Agents Chemother. 1992 Jan;36(1):1–5. doi: 10.1128/aac.36.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Yasuda H., Ajiki Y., Shimozato T., Kasahara M., Kawada H., Iwata M., Shimizu K. Therapeutic efficacy of granulocyte colony-stimulating factor alone and in combination with antibiotics against Pseudomonas aeruginosa infections in mice. Infect Immun. 1990 Aug;58(8):2502–2509. doi: 10.1128/iai.58.8.2502-2509.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. de Lalla F., Maserati R., Scarpellini P., Marone P., Nicolin R., Caccamo F., Rigoli R. Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. Antimicrob Agents Chemother. 1992 Jul;36(7):1567–1569. doi: 10.1128/aac.36.7.1567. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES